Trial Profile
Safety, pharmacokinetic and pharmacodynamic properties of TV-1106, a long-acting GH treatment for GH deficiency
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 02 Feb 2016
Price :
$35
*
At a glance
- Drugs Albusomatropin (Primary)
- Indications Somatotropin deficiency
- Focus Pharmacodynamics; Pharmacokinetics
- 02 Feb 2016 New trial record